Sclareol ameliorates hyperglycemia‐induced renal injury through inhibiting the <scp>MAPK</scp> / <scp>NF‐κB</scp> signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sclareol ameliorates hyperglycemia‐induced renal injury through inhibiting the MAPK / NF‐κB signaling pathway

Published:2022-04-17 Issue:6 Volume:36 Page:2511-2523
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Han Xue¹²,Zhang Jiajia¹,Zhou Li³,Wei Jiajia²,Tu Yu²,Shi Qiaojuan²,Zhang Yi¹,Ren Juan¹,Wang Yi⁴,Ying Huazhong¹³,Liang Guang²⁴^ORCID

Affiliation:

1. Zhejiang Provincial Key Laboratory of Laboratory Animals and Safety Research Hangzhou Medical College Hangzhou China

2. School of Pharmaceutical Sciences Hangzhou Medical College Hangzhou China

3. College of Pharmaceutical Science Zhejiang Chinese Medical University Hangzhou China

4. Chemical Biology Research Center, School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7465

Reference30 articles.

1. Sclareol-loaded lipid nanoparticles improved metabolic profile in obese mice

2. Inflammatory Cytokines in Diabetic Nephropathy

3. The study of sclareol in inhibiting proliferation of osteosarcoma cells by apoptotic induction and loss of mitochondrial membrane potential

4. SGLT2 Inhibitors and the Diabetic Kidney

5. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease;Journal of Ethnopharmacology;2024-10

2. Dihydromyricetin ameliorates diabetic renal fibrosis via regulating SphK1 to suppress the activation of NF-κB pathway;European Journal of Pharmacology;2024-09

3. NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies;Heliyon;2024-05

4. Sclareol ameliorates liver injury by inhibiting nuclear factor-kappa B/NOD-like receptor protein 3-mediated inflammation and lipid metabolism disorder in diabetic mice;International Journal of Immunopathology and Pharmacology;2023-12

5. Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK/ATF6 pathway;International Immunopharmacology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3